Nutraceuticals 2024(4):626642
Telehealth platforms that facilitated peptide prescribing without adequate clinical evaluation protocols, that used offshore prescribers, or that structured their business to generate high-volume prescriptions without individualized patient assessment, have built practices that resemble the GLP-1 compounding enforcement actions the FDA has already pursued
Unfortunately, most are given little guidance, risking issues like malnutrition, muscle loss, and fatigue as they lose weight
The SubQ route provides sustained release with lower peak concentration, while IM provides rapid absorption with higher initial bioavailability but faster clearance
They follow what they understand and is said in a way that builds confidence in the viewer
adults are classified as being either obese or overweight